Antonio Nicolucci, Hungta Chen, Javier Cid-Ruzafa, Andrew Cooper, Peter Fenici, Marilia B Gomes, Niklas Hammar, Kamlesh Khunti, Mikhail Kosiborod, Paul Leigh, Jennie Medin, Wolfgang Rathmann, Marina V Shestakova, Iichiro Shimomura, Afrah Siddiqui, Fengming Tang, Hirotaka Watada, Linong Ji
AIM: To investigate factors associated with health-related quality of life (HRQoL) in patients with type 2 diabetes mellitus (T2D) at initiation of second-line glucose-lowering therapy. METHODS: DISCOVER is a 3-year, prospective observational study of patients with T2D initiating second-line glucose-lowering therapy, conducted in 38 countries. HRQoL at baseline was assessed using the physical and mental component summary (PCS; MCS) scores of the 36-Item Short Form Health Survey version 2 (SF-36v2) in 31 countries (n=8309) and the Hypoglycaemia Fear Survey-II (HFS-II) in 23 countries (n=6516)...
July 21, 2021: Diabetes Research and Clinical Practice